The U.S. is up to 1,168 confirmed measles cases this year. Texas added four cases in the last week, which shows continued ...

A federal judge in California has blocked the Trump administration from enforcing anti-diversity and anti-transgender ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Kennedy Jr., the Trump administration has begun restricting access to COVID vaccines as well as credible vaccine guidance. On ...

The Advisory Committee on Immunization Practices helps the agency make recommendations on who should get certain vaccines.

As summer temperatures climb and families head outdoors, health officials are urging Kansans to take steps to protect ...

The number of reported Lyme disease cases is increasing; here's what you need to know about Lyme disease, and how you can ...

Milwaukee County Executive Davis Crowley held a news conference on Monday, June 9 to stress the importance of recreational ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.